Market Overview:
The global lasix market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of hypertension and congestive heart failure, increasing geriatric population, and growing demand for generic drugs. In addition, the increasing use of lasix in veterinary applications is also contributing to the growth of the market. However, stringent regulatory requirements and side effects associated with lasix are some of the major factors restraining the growth of this market. On basis on type, injection segment accounted for majority share in global lasix market in 2017 and it is projected to maintain its dominance during forecast period 2018-2030 owing to its high usage rates across hospitals & clinics settings worldwide. Tablet segment is anticipated exhibit highest CAGR over forecast period due rising preference for oral medications among patients globally coupled with availability of various dosage strengths over injectable form which may act as a restraint on wider adoption rates over injectable form during forecast period . Oral solution segment held second largest share in overall global lasix product landscape due higher uptake rates across pharmacy setting worldwide followed by hospital & clinics settings respectively . Regionally North America commanded lion’s share (~35%) revenue contribution towards total global sales generated by Lasix drug products throughout 2017 ,followed closely by Europe region (~30%).
Product Definition:
Lasix is a loop diuretic used to treat edema, hypertension, and heart failure. It works by blocking the absorption of sodium and chloride in the kidneys, causing an increase in urine volume. This helps to remove excess fluid from the body tissues.
Injection:
Injection is a medical procedure used to put medication or a drug into the body. Injection allows for more control over the dosage and enables physicians to treat patients more effectively. The most common methods of injection are syringes, pen injectors, auto-injectors, and vials among others.
Tablet:
A tablet is a pharmaceutical composition containing the amount of drug required to treat a disease. It is usually administered to patients in hospitals and clinics. The most common types of tablets used for treatment are effervescent, disintegrating, film-coated, and chewable tablets. Lasix (lacosamide) is an example of such type of tablet used for treating urinary retention caused by blockage in the urethra or bladder neck.
Application Insights:
The largest application of lasix is in the hospital, which accounted for over 75% of the global revenue share in 2017. The growing number of hospitals and healthcare centers has led to an increased demand for anti-cholestrol medicines, including lasix. Moreover, increasing investments by governments in building new hospitals and upgrading existing facilities are expected to drive growth during the forecast period.
The pharmacy segment is anticipated to witness a lucrative CAGR exceeding 9% from 2018 to 2030 owing to rising awareness about health issues among individuals across various regions coupled with rising incidences of heart diseases such as heart attack and stroke that require immediate medical attention. Additionally, increasing disposable income levels coupled with population growth will fuel demand over the forecast period.
Regional Analysis:
North America dominated the global Lasix market in 2017. High prevalence of kidney diseases and growing geriatric population are some of the major factors contributing to its largest share. In addition, increasing healthcare expenditure and rising number of hospital admissions are also expected to drive growth during the forecast period. Rising preference for cost-saving generic drugs is further anticipated to propel market demand over the coming years.
Asia Pacific region is projected to witness a lucrative growth rate during the same period owing to improving economic conditions, high unmet medical needs coupled with rapidly expanding healthcare infrastructure in emerging countries such as China and India which have a large aging population prone to various chronic diseases such as diabetes & hypertension that result in kidney disorders requiring treatment with Lasix tablets or injections.
Growth Factors:
- Increasing prevalence of hypertension and other heart diseases: The number of people suffering from hypertension and other heart diseases is increasing at a rapid pace across the globe. This is expected to drive the demand for Lasix in the coming years.
- Rising awareness about the benefits of using Lasix: There is a growing awareness among people about the benefits of using Lasix for treating various medical conditions. This is likely to boost demand for this drug in the near future.
- Launch of new products by key players: Several key players are launching new products in order to tap into the growing demand for Lasix worldwide. This is likely to fuel market growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Lasix Market Research Report
By Type
Injection, Tablet, Oral Solution
By Application
Hospital, Pharmacy, Clinics
By Companies
Mylan, Sanofi Aventis, Sandoz, Hospira, Hikma, Teva, Sun Pharmaceutical, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
122
Number of Tables & Figures
86
Customization Available
Yes, the report can be customized as per your need.
Global Lasix Market Report Segments:
The global Lasix market is segmented on the basis of:
Types
Injection, Tablet, Oral Solution
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mylan
- Sanofi Aventis
- Sandoz
- Hospira
- Hikma
- Teva
- Sun Pharmaceutical
- Pfizer
Highlights of The Lasix Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection
- Tablet
- Oral Solution
- By Application:
- Hospital
- Pharmacy
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lasix Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lasix (furosemide) is a diuretic medication used to treat high blood pressure, congestive heart failure, and other conditions. Lasix works by increasing the amount of urine produced by the body.
Some of the major companies in the lasix market are Mylan, Sanofi Aventis, Sandoz, Hospira, Hikma, Teva, Sun Pharmaceutical, Pfizer.
The lasix market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lasix Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lasix Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lasix Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lasix Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lasix Market Size & Forecast, 2018-2028
4.5.1 Lasix Market Size and Y-o-Y Growth
4.5.2 Lasix Market Absolute $ Opportunity
Chapter 5 Global Lasix Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Lasix Market Size Forecast by Type
5.2.1 Injection
5.2.2 Tablet
5.2.3 Oral Solution
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Lasix Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Lasix Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lasix Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lasix Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Lasix Analysis and Forecast
9.1 Introduction
9.2 North America Lasix Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Lasix Market Size Forecast by Type
9.6.1 Injection
9.6.2 Tablet
9.6.3 Oral Solution
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Lasix Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.10.3 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Lasix Analysis and Forecast
10.1 Introduction
10.2 Europe Lasix Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Lasix Market Size Forecast by Type
10.6.1 Injection
10.6.2 Tablet
10.6.3 Oral Solution
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Lasix Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.10.3 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Lasix Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Lasix Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Lasix Market Size Forecast by Type
11.6.1 Injection
11.6.2 Tablet
11.6.3 Oral Solution
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Lasix Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.10.3 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Lasix Analysis and Forecast
12.1 Introduction
12.2 Latin America Lasix Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Lasix Market Size Forecast by Type
12.6.1 Injection
12.6.2 Tablet
12.6.3 Oral Solution
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Lasix Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.10.3 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Lasix Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Lasix Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Lasix Market Size Forecast by Type
13.6.1 Injection
13.6.2 Tablet
13.6.3 Oral Solution
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Lasix Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.10.3 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lasix Market: Competitive Dashboard
14.2 Global Lasix Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mylan
14.3.2 Sanofi Aventis
14.3.3 Sandoz
14.3.4 Hospira
14.3.5 Hikma
14.3.6 Teva
14.3.7 Sun Pharmaceutical
14.3.8 Pfizer
